We are live on ! Find out more
RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 93.03%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$646M
AUM Growth
+$88.7M
Cap. Flow
+$74.4M
Cap. Flow %
11.51%
Top 10 Hldgs %
39.44%
Holding
93
New
15
Increased
55
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$15.4M
2
ABBV icon
AbbVie
ABBV
+$13.9M
3
MDT icon
Medtronic
MDT
+$7.15M
4
DHR icon
Danaher
DHR
+$6.5M
5
AGN
Allergan plc
AGN
+$4.92M

Sector Composition

Rank Sector Weight
1 Healthcare 79.22%
2 Industrials 2.23%
3 Financials 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMH
26
DELISTED
Team Health Holdings Inc
TMH
$8.74M 1.35%
150,750
+28,750
+24% +$1.6M
AET
27
DELISTED
Aetna Inc
AET
$8.59M 1.33%
106,000
+13,500
+15% +$1.1M
ISRG icon
28
Intuitive Surgical
ISRG
$134B
$8.54M 1.32%
166,500
-22,950
-12% -$1.14M
BHC icon
29
Bausch Health
BHC
$2.34B
$7.35M 1.14%
56,000
+750
+1% +$89.4K
CAH icon
30
Cardinal Health
CAH
$55.4B
$6.91M 1.07%
92,250
+13,250
+17% +$964K
CI icon
31
Cigna
CI
$74.6B
$6.8M 1.05%
75,000
-20,000
-21% -$1.87M
DHR icon
32
Danaher
DHR
$144B
$6.46M 1%
+126,466
New +$6.5M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$126B
$6.46M 1%
57,500
+11,250
+24% +$1.07M
HTWR
34
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$6.37M 0.98%
82,000
+24,500
+43% +$2.03M
ILMN icon
35
Illumina
ILMN
$28.4B
$6.07M 0.94%
38,036
-6,168
-14% -$1.03M
MWIV
36
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$5.79M 0.9%
39,000
+1,250
+3% +$180K
SRCL
37
DELISTED
Stericycle Inc
SRCL
$5.48M 0.85%
47,000
+5,500
+13% +$650K
OREX
38
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.33M 0.82%
125,000
+34,500
+38% +$1.85M
INCY icon
39
Incyte
INCY
$24.4B
$5.05M 0.78%
103,000
+8,250
+9% +$414K
CTLT
40
DELISTED
CATALENT, INC.
CTLT
$5.03M 0.78%
+201,000
New +$4.44M
NBIX icon
41
Neurocrine Biosciences
NBIX
$16.6B
$4.94M 0.76%
315,000
+5,000
+2% +$74.7K
PBYI icon
42
Puma Biotechnology
PBYI
$454M
$4.89M 0.76%
+20,500
New +$4.21M
TSRO
43
DELISTED
TESARO, Inc.
TSRO
$4.78M 0.74%
177,500
+12,500
+8% +$367K
WCG
44
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.6M 0.71%
76,250
+24,750
+48% +$1.64M
PRTA icon
45
Prothena Corp
PRTA
$450M
$4.49M 0.69%
202,500
+52,500
+35% +$1.11M
RAD
46
DELISTED
Rite Aid Corporation
RAD
$4.42M 0.68%
45,715
+5,715
+14% +$738K
PRGO icon
47
Perrigo
PRGO
$1.78B
$4.28M 0.66%
28,500
A icon
48
Agilent Technologies
A
$41.2B
$4.13M 0.64%
101,355
-31,455
-24% -$1.28M
AGN
49
DELISTED
Allergan Inc
AGN
$4.05M 0.63%
22,750
+6,500
+40% +$1.08M
NVDQ
50
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.93M 0.61%
310,000
+220,000
+244% +$3.2M

Similar funds

Rock Springs Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Rock Springs Capital Management held 93 positions worth $646M, up 16% from $558M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rock Springs Capital Management deployed $74.4M of net new capital in Q3 2014, opening 15 new positions and adding to 55 existing holdings. Its largest new stake was Danaher: 126,466 shares worth $6.46M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 76% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Cigna, an estimated $1.87M trimmed.

  • Rock Springs Capital Management's largest Q3 2014 buy was Danaher: 126,466 shares worth $6.46M.
  • Rock Springs Capital Management added most to HCA Healthcare in Q3 2014, an estimated $15.4M increase.
  • Rock Springs Capital Management's biggest Q3 2014 reduction was Cigna, cutting an estimated $1.87M.
  • Rock Springs Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $23.8M.
  • Rock Springs Capital Management's ten largest holdings make up 39% of its $646M portfolio in Q3 2014.
  • Rock Springs Capital Management opened 15 new positions and closed 10 in Q3 2014.
  • Rock Springs Capital Management's portfolio value rose 16% quarter-over-quarter to $646M.

Based on Rock Springs Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.